Business · 30/09/2019

FDA Announces Fee Rate for Material Threat MCM Priority Review Voucher for FY 2020

The US Food and Drug Administration (FDA) has announced the fee rate for using a material threat medical countermeasure (MCM) priority review voucher for fiscal year 2020. The fee is based on the difference between the average cost of reviewing priority review applications and non-priority review applications from the previous fiscal year.